Navigation Links
Regeneron Announces September 2012 Investor Conference Presentations
Date:8/29/2012

TARRYTOWN, N.Y., Aug. 29, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Robert W. Baird Healthcare Conference at 1:20 p.m. Eastern Time on Wednesday, September 5, 2012
  • Morgan Stanley Global Healthcare Conference at 3:55 p.m. Eastern Time on Tuesday, September 11, 2012
  • UBS Global Life Sciences Conference at 7:30 a.m. Eastern Time on Thursday, September 20, 2012
  • The sessions may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page.  Archived versions of the presentations will be available for thirty days after the live webcasts. 

    Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use.  Regeneron has filed a regulatory application with the U.S. Food and Drug Administration (FDA) for a second indication for EYLEA.  Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information:Manisha Narasimhan, Ph.D.

    Peter DworkinInvestor Relations

    Corporate Communications914-847-5126

    914.847.764

    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
    2. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    3. Regeneron Announces June 2012 Investor Conference Presentations
    4. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
    5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
    7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
    8. Misonix Announces New Distribution Agreement For Panama
    9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
    10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... March 31, 2015 /CNW/ - Today, the Honourable Rona Ambrose, ... animal health organizations to discuss the Government of ... (AMR). The roundtable provided an important ... share their priorities and discuss roles and responsibilities in ... their optimal use (also known as antimicrobial stewardship) was ...
    (Date:3/31/2015)... , Mar. 30, 2015 Research and Markets ... addition of the "Eurpoean Automatic External Defibrillators ... (Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, ... their offering. The European automated external ... a CAGR of 10.9% from 2014 to 2019 ...
    (Date:3/31/2015)... -- According to a new market ... Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, ... - Global Forecast to 2019", published by MarketsandMarkets, ... is expected to reach $48.84 Billion by 2019, ... Browse   9 9 ...
    Breaking Medicine Technology:Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 2Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 3Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 4Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5
    ... Corporation (NYSE: CVS ) today announced that ... repurchase program for up to $4.0 billion of the ... is effective immediately, permits the company to effect the ... open market repurchases, privately negotiated transactions, accelerated share repurchase ...
    ... Inc. (Pink Sheets: GATA ) announced on August 15, ... are currently processing, and they are expecting this number to increase ... company expects to be able to convert at least two thirds ... The company also stated that due to the ...
    Cached Medicine Technology:CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock 2CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock 3Groupe Athena, Inc. Clarifies Previous Guidance 2Groupe Athena, Inc. Clarifies Previous Guidance 3
    (Date:3/31/2015)... Church, Virginia (PRWEB) March 31, 2015 ... relationship with Care Investment Trust LLC ("Care") a ... of Tiptree Financial Inc. Care announces today, their ... third party seller for $54.48 million. Concurrent with ... to affiliates of Greenfield Senior Living ("Greenfield"). Pursuant ...
    (Date:3/31/2015)... 2015 With intravenous (IV) infusion therapy, ... catheter. Patients, typically, are prescribed IV infusion therapy when ... are no longer effective. Illness often leads to ... with electrolyte imbalances. Infusion therapy benefits the patient’s ... to treating dehydration, IV infusion therapy can be used ...
    (Date:3/31/2015)... March 31, 2015 As the scientific ... Energy Balance Network (GEBN) is poised to make ... public health. GEBN is a network of scientists ... Africa, Asia and Oceania who have banded together to ... by the body (energy balance) and apply this understanding ...
    (Date:3/31/2015)... Texas (PRWEB) March 31, 2015 As a ... the value of a good teacher when it comes to ... educators for their instrumental service to the community, Metro Express ... during the summer, all area teachers can be too cool ... teachers and educators put in to help our children get ...
    (Date:3/31/2015)... Fitbody Personal Training LLC invites participants to get ... Saturday morning workouts away from the gym and prepare to ... Personal Training LLC. The classes are moving outdoors. , ... boot camp outdoors on Thursday evenings starting April 2, 2015 ... next session starts on April 11th and ends on May ...
    Breaking Medicine News(10 mins):Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 3Health News:Intravenous Infusion Therapy Now Available at Urgent Care of Texas Centers; Hospital-Level Care in an Outpatient Setting. 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 3Health News:Metro Express Service Launches Educator Discount Program to DFW Teachers 2Health News:FitBody Personal Training LLC Announces its Personal Training Classes are Moving Outdoors 2
    ... activated anxiety-relieving genes, rat research shows , , FRIDAY, June ... cup of coffee in the morning may help ease ... trial indicates. , When rats inhaled the aroma of ... including some that produce proteins with healthful antioxidant activity, ...
    ... Veterans Foundation (BAVF), at its June 14 picnic in ... "We,re honored to recognize Delegate Hixson for her ... to the entire State of,Maryland," said BAVF President John ... legislator and community activist are known,throughout Maryland.", The ...
    ... of Chlamydia trachomatis, the most ... PLEASANTON, Calif., June 13 Roche announced today ... received CE Mark,certification, allowing it to be sold for ... a dual target approach to help ensure,reliability of test ...
    ... Abbott announced new data from,the open-label extension of ... in AS) phase III clinical trial, which showed,HUMIRA(R) ... (AS) for up to three years of treatment ... type of arthritis that primarily causes,inflammation of the ...
    ... 12 Pennsylvania motorcyclists suffered large increases in head ... the repeal of its motorcycle helmet law, according to ... the August issue of the American Journal of ... accounting for increases in motorcycle registrations that occurred during ...
    ... Valuable Patient Care,Resources in Manner True to Their Mission, ... from Los Angeles and Orange Counties demonstrated in front ... Thursday, June 12th to protest the,firm,s anti-union tactics aimed ... System (SJHS), a $3.4 billion dollar corporation,founded by the ...
    Cached Medicine News:Health News:Coffee Beans May Be Newest Stress-Buster 2Health News:Coffee Beans May Be Newest Stress-Buster 3Health News:Blinded Vets Foundation to Honor Maryland State Delegate Sheila Hixson 2Health News:New Roche Chlamydia Test Approved for Use in European Union 2Health News:New Roche Chlamydia Test Approved for Use in European Union 3Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 2Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 3Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 4Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 5Health News:Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years 6Health News:Head injuries increase after motorcycle helmet law repeal 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 2Health News:Caregivers Protest Foley & Lardner's Union Busting & Intimidation 3
    A lower cost alternative to the flagship A3, the A1 retains the essential characteristics of high quality image, simplicity of operation and reliability....
    ... the WASCA Analyzer provides youwith new, exciting ... techniques, the WASCA Analyzeranalyzes the optical properties ... to the retina. In addition to refractive ... order aberrations which were largely ignored in ...
    ... BV Vertical laminar air flow modules ... or medium size sterile work areas, which ... characteristics of Class100 conditions. The modules can ... especially when it is necessary to create ...
    BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
    Medicine Products: